Pre-market: GMO Product Platform 3695.T JPY2137.00 03 Jan 2026: AI 21% upside
Price at the open is JPY 2137.00 and 3695.T is trading pre-market on the JPX as investors watch AI-related service growth that could support re-rating. GMO Product Platform, Inc. (3695.T) is listed on JPX in Japan and reports EPS JPY 64.11 and a reported P/E of 33.33. We use Meyka AI-powered market analysis platform data to connect recent performance, a JPY 9,409,475,988 market cap, and the upcoming earnings date of 2026-02-09 to the AI opportunity for the company.
Quick snapshot and market context
GMO Product Platform, Inc. (3695.T) opened pre-market at JPY 2099.00 and is currently at JPY 2137.00, up JPY 6.00 or 0.28%. Volume is light at 2,200 shares versus a 50-day average of 6,388 shares. Year range is JPY 1850.00 to JPY 3130.00 and the company is traded on JPX in Japan. The Industrials sector has outperformed YTD by 24.22%, which provides a supportive backdrop for specialty services exposed to enterprise AI demand.
Earnings, cash and key fundamentals
Latest disclosed EPS is JPY 64.11 and reported P/E is 33.33 while TTM metrics show a higher PE of 42.60, reflecting recent earnings volatility. Cash per share is JPY 449.90 and book value per share is JPY 535.98, with shareholders’ equity per share JPY 532.16. Current ratio is 2.01, debt to equity is 0.00 (0.00 rounded) and dividend per share is JPY 34.58, implying a dividend yield near 1.62% at today’s price.
AI strategy and growth drivers
GMO Product Platform offers audience engagement and automated data collection services that benefit from AI tooling and panel analytics, positioning it in the AI stocks theme. Revenue per share is JPY 1427.34 and the company has ten-year revenue-per-share growth of 52.93% showing long-term expansion in monetisation. Management highlights AI upgrades and automation as the next revenue tailwind ahead of the next earnings release on 2026-02-09.
Valuation, technicals and Meyka grade
Price-to-sales is 1.50 and price-to-book is 4.02, suggesting premium valuation on profitability and balance-sheet strength; enterprise value to sales is 1.18 and EV/EBITDA is 13.90. Technicals show RSI 52.12, MACD histogram -9.06 and ADX 26.65 indicating a defined trend. Meyka AI rates 3695.T with a score of 76.37 out of 100 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics and analyst consensus. These grades are model-based, not guarantees, and we are not financial advisors.
Risks and catalysts to monitor
Near-term risks include slower AI conversion of existing clients and a valuation reset if operating cash flow growth remains weak; operating income fell 46.63% year-on-year in the latest fiscal update. Catalysts include stronger-than-expected AI contract wins, better operating cash flow, and upside surprises at the 2026-02-09 earnings announcement. Liquidity is modest: average daily volume is 6,388 shares which can widen intraday spreads for larger trades.
Analyst outlook and price forecast
Meyka AI’s forecast model projects a monthly pivot at JPY 1894.27, a quarterly level at JPY 2133.64 and a 1-year projection of JPY 2594.46. Versus the current price of JPY 2137.00, the 1-year projection implies an upside of 21.41% while the monthly model implies a near-term downside of -11.36%. These model outputs are projections and not guarantees; they should be weighed with company guidance and sector trends.
Final Thoughts
GMO Product Platform, Inc. (3695.T) trades at JPY 2137.00 pre-market on JPX with a mixed near-term technical picture but a clear strategic tie to AI-driven survey and audience analytics that could lift revenue per client. Fundamentals show a strong cash position at JPY 449.90 per share and a conservative balance sheet, but TTM profitability metrics produce a premium PE in the low-to-mid 30s and price-to-book near 4.02. Meyka AI’s models show a 1-year projection of JPY 2594.46, implying an upside of 21.41% from today, while a monthly model at JPY 1894.27 implies an -11.36% near-term downside; forecasts are model-based projections and not guarantees. Investors focused on AI stocks should weigh the company’s AI product adoption rate, upcoming 2026-02-09 earnings, and modest liquidity when sizing positions. As an AI-powered market analysis platform, Meyka highlights both the potential upside from AI contracts and the valuation risk if growth stalls, recommending monitoring operating cash flow and client contract metrics for confirmation of the thesis.
FAQs
Pre-market price is JPY 2137.00 and market cap is JPY 9,409,475,988 based on the latest JPX data. Volume is light at 2,200 versus an average of 6,388 shares.
The company’s next earnings announcement is scheduled for 2026-02-09. Investors should watch revenue recognition for AI services and any guidance changes at that release.
Meyka AI’s forecast model projects JPY 2594.46 in one year, implying a 21.41% upside from JPY 2137.00. Forecasts are model-based projections and not guarantees.
Key risks include slower adoption of AI services, weaker operating cash flow, premium valuation (price-to-book 4.02) and limited daily liquidity which can widen spreads on JPX trades.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
